Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
478.00    -1.00 (-0.21%)
Bid:
479.00
Ask:
485.00
Spread: 6.00 (1.253%)
Market Cap: £788.77m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

18 Jan 2011 07:00

RNS Number : 6114Z
Oakley Capital Investments Limited
18 January 2011
 



 

 

18 January 2011

 

Oakley Capital Investments Limited

 

Trading Update for the 12 months ended 31 December 2010

 

·; NAV (unaudited) expected to be in the range of £1.64 - £1.67

o Over 16% up from year ended 31 December 2009

o Over 18p up from 30 June 2010

 

Oakley Capital Investments Limited (AIM: OCL, "OCIL"), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. (the "Limited Partnership" or the "Fund"), today announces a trading update for the 12 months ended 31 December 2010.

 

The Limited Partnership's portfolio of investments comprises Daisy Group plc, Verivox Holdings Limited, Headland Media Limited, Monument Securities Limited, BDO Investment Management Limited and Time Out Limited. Oakley Capital Limited, OCIL's investment adviser, estimates that the Company's net asset value per share, which is subject to the completion of the 31 December 2010 audit of both the Limited Partnership and the Company, will be in the range of £1.64 to £1.67. The OCIL net asset value is made up of cash, the investment in the Limited Partnership and loans provided to a number of the portfolio companies.

 

 

Peter Dubens, Director, commented:

"The second half of 2010 has been very busy for the Limited Partnership with its first realisation in the Fund and two new investments, in BDO Investment Management and Time Out. The exit was from Host Europe Corporation Limited, the Fund's previous largest investment, for total consideration of £222 million, after a holding period of just 31 months.

 

"The Fund's portfolio companies continue to perform well with an improvement in underlying profitability in the remaining investments driving an increase in net asset value per share of at least 14p in the year."

 

For further information please contact:

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens (Director)

Financial Dynamics

+44 20 7831 3113

Juliet Clarke / James Macey-White

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Steven Tredget

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFEFMWFFSEDF
Date   Source Headline
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.